Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 429.90K | 392.20K | 405.80K | 436.10K | 512.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 429.90K | 392.20K | 405.80K | 436.10K | 512.50K |
| Cost of Revenue | 149.40K | 144.80K | 151.30K | 137.30K | 184.00K |
| Gross Profit | 280.40K | 247.30K | 254.40K | 298.70K | 328.50K |
| SG&A Expenses | 1.21M | 1.13M | 1.09M | 1.12M | 1.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.36M | 1.27M | 1.25M | 1.26M | 1.30M |
| Operating Income | -933.00K | -878.50K | -839.80K | -820.80K | -783.60K |
| Income Before Tax | -2.26M | -1.29M | -1.30M | -1.32M | -1.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.26 | -1.29 | -1.30 | -1.32 | -1.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.26M | -1.29M | -1.30M | -1.32M | -1.23M |
| EBIT | -933.00K | -878.50K | -839.80K | -820.80K | -783.60K |
| EBITDA | -925.20K | -870.90K | -832.30K | -809.70K | -769.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 30.73B | 30.69B | 30.58B | 30.54B | 30.48B |
| Average Diluted Shares Outstanding | 30.73B | 30.69B | 30.58B | 30.54B | 30.48B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |